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Abstract
In the mammalian testis, preleptotene and leptotene spermatocytes residing in the basal compartment of the seminiferous epithelium must
traverse the blood-testis barrier (BTB) during spermatogenesis, entering the adluminal compartment for further development. However, until
recently the regulatory mechanisms that regulate BTB dynamics remained largely unknown. We provide a critical review regarding the
significance of cytokines in regulating the ‘opening’ and ‘closing’ of the BTB. We also discuss how cytokines may be working in concert with
adaptors that selectively govern the downstream signaling pathways. This process, in turn, regulates the dynamics of either Sertoli–Sertoli
tight junction (TJ), Sertoli–germ cell adherens junction (AJ), or both junction types in the epithelium, thereby permitting TJ opening without
compromising AJs, and vice versa. We also discuss how adaptors alter their protein–protein association with the integral membrane proteins at
the cell–cell interface via changes in their phosphorylation status, thereby altering adhesion function at AJ. These findings illustrate that the
testis is a novel in vivo model to study the biology of junction restructuring. Furthermore, a molecular model is presented regarding how
cytokines selectively regulate TJ/AJ restructuring in the epithelium during spermatogenesis.
# 2005 Published by Elsevier Ltd.
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1. Introduction
The production of mature spermatozoa (haploid, 1n) from
spermatogonia (diploid, 2n) is essential for the perpetuation of
all mammalian species. Such event, known as spermatogen-
esis in the male, takes places in the functional unit of the testis
called the seminiferous tubule. Seminiferous tubules, in turn,
coordinate with Leydig cells in the interstitium and the brain
via the hypothalamic-pituitary-testicular axis to regulate
spermatogenesis [1,2]. Although spermatogenesis varies in
detail in different species (e.g., minks are seasonal breeders
exhibiting seasonally or environmentally responsive phases in
this process whereas spermatogenesis continues throughout
the entire life span in humans and rodents), the cellular
constituents and the basic physiology of the testes are rather
similar [3]. We limit our discussion largely in rats, mice and/or
men since most studies were conducted in these species.
Spermatogenesis can be divided into three distinct phases
which provide an upward of 150  106 spermatozoa per
day per man [1,3]. The germline stem cells spermatogonia
can either self-proliferate (phase 1) or differentiate into
primary spermatocytes, which then undergo meiosis and
differentiate into secondary spermatocytes and eventually
haploid spermatids (phase 2). These cells, in turn,
differentiate morphologically and functionally to sperma-
tozoa via spermiogenesis (phase 3), which are released into
the tubule lumen at spermiation [1,3]. This entire process of
germ cell development in the seminiferous epithelium is
dependent on temporal and spatial expression of unique sets
of genes and proteins. In the rat testis, an epithelial cycle
(12–14 days duration) can be divided into 14 stages which
are classified according to the unique germ cell types that
associate with Sertoli cells in the epithelium [3,4]. It takes
58 days for a single spermatogonium to fully differentiate
and develop into 256 spermatozoa. As such, it takes 4.5
epithelial cycles for one spermatogonium to differentiate
into 256 spermatids. For each stage, at least four germ cell
types are present in the epithelium that are organized
www.elsevier.com/locate/cytogfr
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Fig. 1. Spermatogenesis and cell junctions in the seminiferous epithelium of the mammalian testis (e.g. rats). (A) This is the cross-section of a seminiferous
tubule from an adult rat testis showing the intimate relationship between Sertoli cells (N, Sertoli cell nucleus) and germ cells (e.g., pachytene spermatocyte PS,
round spermatid RS). (B) Schematic drawing of developing germ cells and their intimate relationship with Sertoli cells during spermatogenesis in the
seminiferous epithelium. Also shown is the relative location of different junction types in the epithelium between Sertoli cells as well as between Sertoli and
germ cells. Sertoli and germ cells constitue the seminiferous epithelium that is adjacent to the tunica propria. Differentiating germ cells must migrate from the
basal to the adluminal compartment, traversing the BTB, which has physically divided the epithelium into the basal and adluminal compartment. (C–E) Electron
micrographs of cross sections of seminiferous epithelium illustrating the ultrastructural features of the blood-testis barrier at low (C) and high (D) magnification.
The basal ES is characterized by the presence of actin filament bundles (white arrows) sandwiched between the cisternae of endoplasmic reticulum (er), and the
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spatially into layers from the base to the lumen of the
seminiferous tubule [3,4]. Furthermore, spermatogenesis
cannot completewithout the support of Sertoli cells, which are
the only other cell type in the seminiferous epithelium behind
the BTB besides germ cells (note: the BTB has physically
divided the epithelium into the basal and adluminal
compartment, see Fig. 1) [5–7]. Except for the spermatogonia,
developing germ cells move progressively toward the lumen
[8]. For instance, preleptotene and leptotene spermatocytes
that lie at the periphery of the tubule and outside the BTB must
traverse the BTB at late stages VIII and early IX of the
epithelial cycle [8].
It is conceivable that enormous Sertoli–germ cell
interactions take place in the seminiferous epithelium
throughout spermatogenesis [1–4,6,9,10]. If one views
spermatogenesis as a voyage of a germ cell that moves from
the basal to the adluminal compartment while developing to a
mature spermatozoon, this process involves numerous
decision makings and executions. It also requires signalings
in and out of germ cells to facilitate this event. Although it is
not entirely clear regarding the sequence of these signals,
there are at least two sources: external signals from outside the
tubule (e.g., via Leydig cells, peritubular myoid cells, and
both paracrine and hormonal factors including those from the
pituitary gland), and internal crosstalks between germ and
Sertoli cells (e.g., integrin-mediated signalings) [5,6,11,12].
The phenotypic consequence of these signalings is mani-
fested, at least in part, via the constant remodeling at the
Sertoli–Sertoli and Sertoli–germ cell interfacewhere different
cell junction types are present [1,2].
The identities of these signals and the details of the
remodeling events have become increasingly clear in recent
years [1,2]. For instance, there is accumulating evidence that
illustrates the crucial roles of cytokines pertinent to sperma-
togenesis and junction restructuring [2]. In this review, we first
give an update on the junction complexes that are found in the
testis, highlighting how cytokines (e.g., TGF-b3, TNFa) can
affect junction dynamics and how these signals are being fine-
tuned to allow their regulation of a particular junction type.
2. The seminiferous epithelium: Sertoli–germ cell
junctions and spermatogenesis
2.1. Seminiferous epithelium
The seminiferous epithelium is composed of Sertoli and
germ cells. The Sertoli cell is by and large a tall columnar
cell extending from the base to the apex of the seminiferous
tubule [3]. It is physically reshaped by germ cells to possess
many cytoplasic processes because each Sertoli cell is
‘nursing’ about 30–50 germ cells at different stages of their
development at any given time during the epithelial cycle
[13,14]. In the rat, Sertoli cells cease to proliferate at about
day 20 postnatal and the number of these nursing cells
determines how many germ cells can be supported and
produced via spermatogenesis in the testis [3], illustrating
the crucial function of Sertoli cells. For instance, Sertoli
cells provide structural support for germ cells and their
translocation, create the BTB and define the polarity of the
epithelium, secrete numerous biological factors and
nutrients for germ cells, and conduct other vital functions
pertinent to spermatogenesis (e.g., phagocytosis) [2,3,14].
2.2. Sertoli–Sertoli and Sertoli–germ cell junctions
The different junction types that are found in the
seminiferous epithelium have recently been reviewed [1,2].
Similar to other epithelia or endothelia, virtually all major
junction types are found in the testis. Besides the tight
junctions that are restricted to the BTB, several anchoring
junction types (four are found in most epithelia) are also
detected in the testis: (a) adherens junction (including basal
and apical ectoplasmic specialization [ES], basal and apical
tubulobulbar complex [TBC]); (b) desmosome-like junctions;
and (c) hemidesmosomes (for reviews, see [1,2,10,15]). ES is
a testis-specific, actin-based adherens junction localized at
two sites in the seminiferous epithelium: basal and apical
compartment (see Fig. 1) [2,9,10,16,17]. Basal ES is limited
to BTB and present side-by-side with TJ (Fig. 1). Apical ES is
found between elongating/elongate spermatids and Sertoli
cells. At least three protein complexes, namely, the cadherin/
catenin, the nectin/afadin, and the integrin/laminin, are known
to be ES components [2,17]. TBC is another modified AJ type
found in the testis [2,10,18]. Apical TBC only appears a few
days before spermiation in the epithelium at late stage VIII of
the epithelial cycle when apical ES begins to disappear
whereas basal TBC co-exists with TJ, basal ES, and
desmosomal-like junctions at the BTB site. Desmosome-like
junctions are present between Sertoli cells and spermatogo-
nia, spermatocytes and round spermatids, being most
prominent surrounding pachytene spermatocytes [10]. The
BTB is not fully formed until 16–19 days postnatal in the rat
testis [3]. Unlike barriers in other organs (e.g., the blood–brain
barrier, the blood–retinal barrier) where TJs are localized to
the apical region of the epithelium/endothelium, to be
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Sertoli cell membrane (apposing arrowheads represent the apposing Sertoli cell membranes), which can be found on both sides of the apposing Sertoli cells.
Tight junction (TJ) is found between the basal ES, the coexisting TJ and basal ES in turn constitute the BTB. Apical ES is shown in (E) which is typified by the
presence of actin filament bundles (white arrowheads) sandwiches between the cisternae of er and Sertoli cell membrane (apposing white arrowheads represent
the apposing Sertoli and germ cell membranes). However, this typical feature of ES, in contrast to the basal ES, is restictied only to the Sertoli cell side in apical
ES. (F–G) Schematic drawings that illustrate the molecular architecture of the constituent proteins at the BTB (F) and apical ES (G), which include cytokines
(e.g., TGF-b3 and TNFa) released from Sertoli and/or germ cells can mediate Sertoli–germ cell crosstalk during spermatogenesis. The protein complexes
known to exist at the apical ES site include cadherin/catenin, nectin/afadin, and a6b1 integrin/laminin g3; whereas occludin/ZO-1, JAM/ZO-1, claudin/ZO-1,
cadherin/catenin and nectin/afadin are found at the BTB site. Bar in E = 10 mm, C = 3 mm, D = 0.25 mm and E = 0.3 mm, respectively.
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followed by AJ, and TJs are furthest away from the ECM; TJs
at the BTB lie closest to the basement membrane (a modified
form of ECM). Furthermore, BTB is a dynamic structure
which must ‘open’ and ‘close’ to permit preleptotene/
leptotene spermatocyte transmigration. BTB is a rather
complex barrier when compared to other barriers (e.g.,
gastric–mucosal barrier which is formed by epithelial cells,
blood–retinal barrier and blood–brain barrier which are
formed by endothelial cells) [19–21] (see Fig. 1). Recent
studies have also shown that apical ES is constituted and
regulated by proteins that are usually restricted to the focal
contact in cell–matrix interface in other epithelia [22]. This
hybrid cell–matrix–cell junction type may indeed be essential
for rapid junction remodeling to facilitate spermatids
orientation and movement at spermiation.
2.3. Constituent proteins of different junction types in
the testis
2.3.1. Tight junction (TJ)
TJ is the only known example of occluding junction that
confers the barrier function of an epithelium or endothelium
by restricting the passages of molecules through the
intercellular spaces and creates a boundary that defines cell
polarity [23]. In the testis, TJ also creates an immunological
barrier that sequesters the post-meiotic germ cell antigens
from the immune system of the host animals. The currently
known TJ integral membrane proteins include JAMs
(junctional adhesion molecules), claudins and occludins,
which have recently been reviewed [1,2,23,24], as such, only
a brief update is provided in this section.
2.3.1.1. JAMs. JAMs are members of a distinct class of cell
adhesion molecules typified by the presence of two Ig-like
loops in the extracellular domain that are expressed in
leukocytes and are localized to tight junctions as integral
membrane proteins in epithelial and endothelial cells
[25,26]. Since the discovery of JAM-A in 1998 [27], other
members, including the more related JAM-B and JAM-C,
and the less related JAM4, coxsackie and adenovirus
receptor (CAR), and endothelial cell-selective adhesion
molecule (ESAM), have recently been added to the list
[25,26,28]. The presence of JAM-A, B and C in the testis
have now been confirmed [29,30]. JAM-A is present at the
BTB in the rat testis, co-localizing with ZO-1 [30].
Moreover, JAM-A expression is stage-specific, being
highest at IX–XIV, lowest at IV–VI [30]. This stage
specificity apparently is related to its possible involvement
in BTB dynamics, facilitating the passage of preleptotene/
leptotene spermatocytes across the BTB. Although Jam-A/
 mice has been generated, it is not known if the BTB is
affected since a morphological examination of the testis has
yet to be reported [31]. A recent study on the Jam-C/ mice
have shown that JAM-C is crucial to spermiogenesis since in
the viable mutants, mature spermatids are missing [29]. In
normal mice, JAM-C is localized to the developing round
and elongating spermatids [29]. Interestingly, JAM-B has
been localized both to the site of TJs at the basal
compartment and to the apical ES at the spermatid-Sertoli
cell interface in the seminiferous epithelium, outside the
BTB [29]. Besides their homophilic interactions amongst
JAM-A, B and C, JAM-C can interact with JAM-B
heterotypically [32]. Both JAM-B and JAM-C are localized
to the heads of spermatids at the apical ES, and this
heterophilic association may be important for the Sertoli
cell-spermatid adhesion function [29]. Based on currently
available data, two roles are suggested for JAMs: in the
immune system they are crucial to leukocyte transmigra-
tion; and in polarized epithelial and endothelial cells, they
seem to take part in organizing TJ and cell polarity [26].
This latter physiological role has been extended to the testis
since the cell polarity complex [partitioning-defective (Par)
3/atypical protein kinase C (aPKC)/Cdc42] apparently is
recruited by JAM-C to facilitate round spermatid polariza-
tion and thus differentiation [26]. How JAMs assist
preleptotene/leptotene spermatocytes to traverse the BTB
similar to neutrophil transmigration across the endothelial
TJ-barrier remains to be investigated since germ cells per se,
unlike neutrophils or macrophages, are not actively migrating
cells. It is possible that JAMs are associated with other
motor proteins (e.g., myosin VIIa) and cytoskeletons (e.g.,
actin, tubulin) that facilitate germ cell movement using
the locomotive apparatus in Sertoli cells that provides the
necessary protrusive force to guide germ cell movement
(for review, see [2]).
JAMs are expressed in multiple epithelia, endothelia,
leukocytes and platelets [25,26]. The regulation of JAMs in
the testis is largely unknown. In the rat testis, when the
intratesticular T was suppressed by placing testosterone and
estrogen implants subdermally, spermatids (step 8 and
beyond) were depleted because of a disruption of the cell
adhesion at the ES [30,33–36]. However, the tight junctions
at the BTB remained intact which were associated with a
significant surge in the levels of JAM-A, occludin and ZO-1
in the epithelium [30]. Indeed, the JAM-A distribution at the
BTB site in the basal compartment of the seminiferous
epithelium was significantly induced and intensified,
becoming a thickened and prominent ring surrounding the
entire tubule [30]. It is apparent that a depletion of androgen
in the testis triggers a novel mechanism that leads to two
distinctive events: germ cell loss and a reinforced BTB [30].
Another model using Adjudin to induce germ cell sloughing
from the epithelium in adult rat testes has yield similar
results in which JAM-A expression was induced at the time
of germ cell depletion (unpublished observations). Although
the compounds that were used to trigger the changes in the
epithelium are different in these two models, namely
androgen suppression and Adjudin, the signaling events
(e.g., both treatments activate the integrin/focal adhesion
kinase signaling pathway) and the phenotypic outcome (e.g.,
germ cell loss from the epithelium and a reinforced BTB) are
similar [36,37]. This seemingly suggests that JAM-A is
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regulated, at least in part, by a mechanism downstream of
lowered intratesticular T level that triggers germ cell
sloughing from the epithelium. It is not known if cytokines
are the upstream regulators of JAMs. An earlier report has
shown that TNF and IFN-g treatment of human umbilical
vein endothelial cells can reduce cell surface expression of
JAM-A, but these cytokines have no effects on the rate of
transmigration of neutrophils [38].
2.3.1.2. Claudins. The claudin superfamily of TJ integral
membrane proteins consists of at least 24 members with Mr
ranging between 20 and 27 kDa [39,40]. Claudins have a
unique expression profile in a tissue [39]. For instance,
claudin-1 and claudin-11 are expressed in the testis, mostly
restricted to Sertoli cells, and the brain, whereas more than 10
claudin members are expressed in the kidney [39]. In the
testis, the expression of claudin-3, -4, -5, -7, -8 has also been
reported [2,41]. Claudin-11, also known as oligodendrocyte-
specific protein (OSP), is the best studied claudin in the testis
[42–46]. Cld-11/ mice were sterile and were associated
with the absence of TJ strands in the seminiferous epithelium
and in the myelin sheath in the brain [46]. Claudin-11 is
known to be up-regulated by androgens [42,47] and down-
regulated by TGF-b3 [44] in Sertoli cells cultured in vitro.
Claudin-11 expression is high from postnatal days 10–16 in
the rat testis corresponding to the maturation of BTB [43].
Anti-androgen, such as flutamide, can also inhibit the
expression of claudin-11 in prepubertal rat testes [42].
Claudin-11 is also important for hearing function since
Cld11/ mice lacking TJ in the basal cells of stria vascularis
in cochlea failed to compartmentalize the endolymph and
suppressed electrical potentials [48].
TJ strands in the intercellular junction are not a static but
dynamic structure. A recent study by real-time imaging to
examine the behavior of exogenously expressed claudin-1
in mouse L fibroblasts showed that the paired claudin
strands underwent constant and dynamic reorganization
while maintaining the structural integrity of the entire
TJ network [49]. Internalization of claudin-3 was also
observed via endocytosis in confluent epithelial cells, after
it was dissociated from other TJ components, such as JAM,
occludin and ZO-1 [50]. This dynamic nature of claudins,
plausibly applicable to other TJ constituent proteins, is
not entirely unexpected since TJ barriers must undergo
conformational changes to accommodate paracellular
transport of substances, such as during food adsorption
in the small intestine. For the BTB, it has to be ‘opened
(or ‘dissolved’ ?) and then ‘closed’ (or ‘regenerated’ ?)
frequently to facilitate germ cell passage while maintaining
the barrier function during the epithelial cycle. It is likely
that such reorganization of claudin strands, possibly also of
occludin- and JAM-constituted TJ strands, are occurring at
the BTB. The uncoupling of TJ proteins may indeed be a
prerequisite for the dual roles played by the BTB during its
restructuring to permit germ cell passage while maintaining
the barrier function simultaneously.
2.3.1.3. Occludin. Occludin is the first TJ integral mem-
brane protein found in epithelia [51] and is the most studied
in this category. Occludin is known to be regulated by
cytokines in the testis (e.g., TGF-b2, TGF-b3) [44,52].
Other signaling events are recently shown to engage in its
regulation as well. In the androgen-suppressed rat testes to
induce germ cell loss from the epithelium, occludin
expression, similar to JAM-A, is significantly induced,
resulting in prominent staining at the BTB when Sertoli–
germ cell adhesion function was compromised [30]. This
also reinforces the notion that the regulation of TJ proteins is
essentially different from that of AJ proteins in the rat testis.
Occludin is also regulated, at least in part, by ubiquitination
[53]. Itch (an E3 ubiquitin ligase) and UBC4 (an ubiquitin-
conjugating enzyme) are reciprocally regulated versus
occludin during Sertoli cell TJ assembly or disassembly,
and ubiquitin-conjugated and Itch-conjugated occludin are
detected when the dibutyryl-cAMP-induced degradation of
occludin is blocked by a proteasome inhibitor MG-132 [53].
Other cytokines, such as TNFa, IL-1b, IFN-g, can also
affect occludin expression and its distribution at TJs in
multiple epithelia and endothelia [54–56]. It is not known if
these cytokines can exert any effect on occludin expression
or its cellular distribution at the BTB. But TNFa has been
shown to perturb TJ-barrier function in Sertoli cell cultures
[57] and can cause germ cell exfoliation in the rat testis after
its systemic administration [58]. Recent studies have shown
that TNF and IFN-g can indeed regulate occludin
transcription by diminishing its promoter activity [55].
2.3.2. Anchoring junction
2.3.2.1. The cadherin/catenin protein complex. Cadherins
are transmembrane glycoproteins that mediate calcium-
dependent cell–cell adhesion in multiple epithelia including
the seminiferous epithelium in the testis [59,60]. The
cadherin superfamily consists of over 80 members that fall
into at least six subfamilies, which include (i) the type I
classical cadherins (e.g., E-cadherin, N-cadherin, P-cad-
herin) and its highly related; (ii) type II classical cadherins
(e.g., VE-cadherin); (iii) desmosomal cadherins (desmo-
collins and desmogleins); (iv) protocadherins; (v) seven-
pass transmembrane cadherins (Flamingo); and (vi) Fat-like
cadherins [59–62]. Type I classical cadherins are the best
studied cadherins in multiple tissues including the testis.
Besides the classical cadherins, the presence of other
subfamilies in the testis, such as protocadherins, Fat and
Flamingo, has also been detected by RT-PCR [63], but their
function in the seminiferous epithelium are less known.
During development, the expression of different cadherins is
highly dynamic [64] and this seems to be applicable to the
testis as well since the expression profile of cadherins varies
with the age and cell types in the rat testis where at least 24
cadherins are known to be present [63]. For instance, N-
cadherin is predominantly localized to the basal ES and the
periphery of the seminiferous tubules with restricted and
stage-specific localization at the apical ES [30,65–69],
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whereas E-cadherin is relatively more abundant in germ
cells [63,66]. A smaller amount of N-cadherin in the testis
appears also to be a component of desmosomal-like
junctions which is a hybrid junction type of desmosome
and gap junctions [65,67]. Indeed, N-cadherin has been
shown to link to both actin microfilament and microtubules
in the testis [66]. A recent report has also illustrated that
protocadherin a3 is associated with spermatids at the
acrosomal area, intercellular bridge as well as flagellum,
distinct from the distribution of classical cadherins [70].
Classical cadherin-based protein complex comprising of
the transmembrane protein cadherins and intracellular
adaptor catenins is a well defined focal point of cell
adhesion and signaling [59,71]. b-Catenin and g-catenin
connects cadherins to a-catenin and a-actinin, which are
two putative actin binding proteins [72]. Phosphorylation of
b-catenin can in turn regulate the integrity of the cadherin/
catenin complex [73]. In both Adjudin- and androgen
suppression-induced germ cell loss models, the event of
germ cell loss is facilitated by the dissociation of N-
cadherin from b-catenin [30,35,68]. Indeed, increased
tyrosine phosphorylation of b-catenin was detected at the
time of germ cell depletion in these models [30]. Kinases
and phosphatases are also known to regulate cadherin/
catenin association [35,74,75]. For instance, myotubularin-
related protein 2 (MTMR2), a lipid phosphoinositide
phosphatase, was shown to interact with the kinase c-Src
[35] and c-Src in turn associates with the N-cadherin/b-
catenin complex [74]. This illustrates a novel regulatory
mechanism may be in place in the testis regarding the
cadherin/catenin-mediated cell adhesion function in which
MTMR2 and c-Src regulate the phosphorylation status of
the cadherin/catenin, which in turn determines its cell
adhesive function. More recent studies have shown that the
N-cadherin/b-catenin adhesion unit can also be regulated
by the equilibrium between IQGAP-1 (IQ motif containing
GTPase activating protein, an effector of Cdc42 GTPase)
and Cdc42 in Sertoli–germ cell AJ [76]. For instance, using
a Ca2+ switch model, it has been demonstrated that at low
Ca2+ level, IQGAP-1 is released from Cdc42, and interacts
with b-catenin instead, causing the dissociation of b-
catenin from N-cadherin, and germ cell depletion from
Sertoli cells [76].
E-Cadherin is also a tumor suppressor which is down-
regulated while N-cadherin is up-regulated during epithelial
tumor progression [64,77,78]. This ‘cadherin switch’ further
illustrates the unique yet pivotal role of each cadherin in cell
adhesion and cell motility. It is not clear if such dynamic
switch-over between different cadherins occur during germ
cell movement in the seminiferous epithelium. However,
N-cadherin can become highly expressed in the testis of
Adjudin treated rats during germ cell loss from the
epithelium [66–68]. N-cadherin is also up-regulated in
androgen suppressed rat testes during germ cell loss [30,35].
Yet such a surge in N-cadherin cannot rescue germ cell loss
from the epithelium since a loss of association between N-
cadherin and b-catenin was detected at the time of germ cell
sloughing in both models [30,35]. It seems that such an
induction of cadherins reinforces the BTB integrity since N-
cadherin is also a component protein of the BTB in the rat
testis.
2.3.2.2. The nectin/afadin/ponsin/ADIP complex. The nec-
tin/afadin/ponsin complex is another actin-based cell
adhesion protein complex that plays a crucial role in the
testis during spermatogenesis. It confers Sertoli–germ cell
adhesion function particularly for elongating/elongate
spermatids [1,2,68,79]. Four nectins (nectin-1, -2,-3, and -
4) have been identified thus far, all of which are expressed in
the testis with nectin-2 and nectin-3 being the highly
expressed [2,80–82]. Nectin-3 is restricted exclusively to
elongating/elongate spermatids which can heterotypically
interacting with nectin-2 on the Sertoli cell side [68,83].
Spermatozoa from nectin-2/ mice were morphologically
aberrant and functionally impotent [83–85]. Since nectins
are capable of activating Cdc42 via c-Src and a Cdc42 GEF
(GDP/GTP exchange factor) [86], or activating Rac, thus
recruiting the polarity complex Par3/aPKC/Par6 to the
apical ES site [87], the absence of nectin-3 may also lead to
malfunctioning of spermatid polarization, similar to Jam-
C/ mice [29]. Nectins are known to initiate cell–cell
contacts by recruiting cadherin and JAM-A to establish
functional AJ and TJ in epithelial cells [79,87–89]. It is
likely that nectin-2/-3 and JAM-B/-C can also interact with
each other since they are all localized to the elongating/
elongate spermatids at the apical ES site, which should be
investigated in future studies. In the Adjudin-induced germ
cell loss model, it was found that the nectin-3/afadin
interaction became severely weakened before any obvious
reduction in their protein levels was detected [68],
illustrating this cell adhesion unit must be compromised
to facilitate spermatid loss (Table 1).
Besides afadin and ponsin, cytoplasmic adaptors that link
nectin to the actin-based cytoskeleton [79], a new adaptor
protein ADIP (afadin DIL domain-interacting protein) has
recently been localized to AJ sites that interacts with both a-
actinin and afadin, providing additional cytoplasmic link
between nectin- and cadherin-based cell adhesion units
[90,91]. ADIP is highly expressed in the mouse testis [90].
Another possible linker that binds to both afadin and a-
actinin is LMO7 (LIM domain only 7), however, its presence
in the rat testis failed to be confirmed by immunoblot
analysis [92].
Nectin-like (Necl) molecules are similar to nectins, but
do not bind to afadins [87,88]. This group of calcium-
independent cell adhesion molecules consists of five
members, capable of homo- or heterophilic interactions
with nectins, and are important cell–cell adhesion molecules
in various tissues [87,88]. At least Necl2 has been shown to
be highly expressed in the rat testis [93]. It will be important
to explore the significance of Necls in the testis, which is
likely to involve in Sertoli–germ cell adhesion function.
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2.3.2.3. The integrin/laminin complex. The integrin/lami-
nin protein complex has recently been identified at the apical
ES which confers Sertoli–germ cell adhesion and provides a
new platform regarding how these two cell types interact
with each other and coordinate spermatogenesis [37,94].
Integrin-based protein complexes are usually found at the
cell–matrix junctions, such as hemidesmosomes or focal
adhesion, which further connects to the intermediate
filament or actin bundles, with integrin also capable of
serving as a cell receptor for the ECM [95,96]. Interestingly,
the junctions between Sertoli and germ cells are not simple
cell–cell junction types; rather, they are a hybrid of both
cell–cell and cell–matrix junction types, probably to
facilitate rapid junction turnover and germ cell migration
during spermatogenesis [22]. Several recent reviews on the
role of integrins and ECM in the testis are available, thus this
information is not discussed herein [22,97].
3. Cytokines are key regulators of junction dynamics
in the testis
Cytokines are regulatory peptides (usually 30 kDa in
size) produced virtually by every nucleated cells in
mammals and have pleiotropic actions on cell physiology
as an autocrine or paracrine factor [98]. In the testis, Sertoli
and germ cells produce a number of cytokines, including
members of the TGF-b superfamily (e.g., TGF-bs, activins,
inhibins), platelet-derived growth factor (PDGF), interleu-
kins (e.g., IL-1, IL-6, IL-11), tumor necrosis factor (e.g.,
TNFa, Fas ligand), interferons (e.g., IFN-a, IFN-g),
fibroblast growth factor (FGF), nerve growth factor
(NGF), and stem cell factor (or steel factor) (for reviews,
see [1,2,11,99,100]) (see also Table 2). These cytokines likely
mediate crosstalk between Sertoli and germ cells to facilitate
germ cell movement across the seminiferous epithelium and
other cellular events in the epithelium during the epithelial
cycle such as germ cell differentiation. Herein, we critically
evaluate two best studied cytokines, namely TNFa and TGF-
b3, regarding their significance in spermatogenesis in the
testis and briefly summarize the action of other cytokines.
3.1. TNF
TNF, also known as TNFa or cachectin, is synthesized as
a 26 kDa type II transmembrane prepeptide (pro-TNF),
which is subsequently activated by proteolytic cleavage to
release the C-terminal 17 kDa mature protein by the TNF-
converting enzyme (TACE). The mature protein is formed
by aggregates creating a homotrimer that can bind to two
types of receptors: TNFR1 and TNFR2 [101,102]. The
major source of TNFa in mammalian body is immune cells
such as macrophage and monocytes, but TNFa is also
produced by other non-immune cells including astrocytes,
keratinotytes, Sertoli cells and germ cells [57,101]. TNF
signaling is mediated mainly through TNFR1, which has
distinct domains that facilitate the recruitment of other
intracellular adaptors to activate signaling pathways. The net
result of such activation can modulate apoptosis, inflamma-
tion and cell proliferation [101,103]. These adaptors include
TNFR1-associated death domain protein (TRADD) which
can recruit Fas-associated death domain protein (FADD),
TNF receptor associated factor-2 (TRAF-2), or receptor-
interacting protein (RIP), to induce the caspase-mediated
apoptosis, activate transcription factors (e.g., c-jun, c-fos,
ATF-2) via MAPK (ERK, JNK and p38), or activate nuclear
factor kappa B (NFkB) through inhibitor of NFkB kinase
(IKK), respectively [101–103]. A TNFR1 scaffolding
protein called TGFR-associated ubiquitous scaffolding
and signaling protein (TRUSS) has recently been cloned
and characterized [104]. The expression of TRUSS is
enriched in heart, liver and testes, it is also known to interact
with TRADD, TRAF-2 and IKK [104]. In addition to these
complex signaling networks that can be activated down-
W. Xia et al. / Cytokine & Growth Factor Reviews xxx (2005) xxx–xxx 7
DTD 5
CGFR 365 1–24
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
Table 1
Cytokine-mediated regulation of junction component proteins in epithelia including the testis
Junction component Protein Cytokine/hormone that modulates the steady-state
mRNA/protein level (+/) or protein distribution pattern
(d) of the target junction protein
Selected references
TJ-integral membrane JAM-A TNF (d), IFN-g (d), T#(+) [30,38]
Occludin TGF-b3 (), HGF (/d), TNF (/d), IFN-g (/d), VEGF
(/d, inhibited by ANP), IL-1b (/d), IL-4 (), IL-13 (), MCP-1 (), T#(+)
[44,52,54–56,223–225]
Claudin TGF-b3 (), TNF (), FSH/cAMP () [43,44]
AJ-integral membrane N-Cadherin HGF (+), EGF (+), TGF-b (+/d), T (+), T# (+), IL-6 () [30,66,78]
E-Cadherin TGF-b (/d), T (+) [52,66,68]
Nectin-3 TGF-b3(/d) [52,68]
Integrin-b1 TGF-b (+), T#(+), [30,226]
Adaptor ZO-1 TGF-b (d), IL-4 (), IL-13 (), T#(+) [30,225]
Afadin TGF-b3(/d) [68]
b-Catenin TGF-b (d), T#(+) [30,139,227]
a-Catenin TGF-b (d), T#(+) [30,139,227]
T#, suppression of intratesticular testosterone level with the use of testosterone (T) and estradiol implants; +, stimulation;, inhibition. Protein distribution pattern
was assessed by either immunofluorescent microscopy or immunohistochemistry using testicular cells cultured in vitro or seminiferous epithelium in vivo.
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Table 2
Cytokines and their functions in the testis
Group Cytokine KO mice Cellular expression Function in the testis References
TGF-b TGF-b1 Perinatal/neonatal lethal Sertoli, Leydig, germ, myoid cells Testicular development [109,112,119,123]
TGF-b2 Perinatal lethal Sertoli, Leydig and germ cells Testicular development
TGF-b3 Perinatal lethal Sertoli and germ cells Junction dynamics
Activin/inhibin bA Perinatal lethal Sertoli and peritubular cells Regulate FSH production, testicular development [109,228]
Activin/inhibin bB Viable/reproductive
abnormality (female)
Sertoli cells, germ cells
BMP-4 Embryonic lethal (/)/
lowered fecundity (+/)
Pachytene spermatocytes,
Sertoli cells (early postnatal)
Maintain spermatogenesis; spermatogonia differentiation [109,229–231]
TNF TNFa Viable/fertile Sertoli, germ cells Repress steroidogenesis, disrupt TJ, inhibit GC apoptosis [57,106–108,218,232]
FasL Viable Spermatocytes/spermatids;
Sertoli cell (?)
Induce apoptosis, preserve immune-privilege [233–235]
TRAIL Viable/fertile Germ, Leydig cells GC apoptosis [236,237]
Growth factors EGF Viable/fertile Sertoli, germ cells Maintain spermatogenesis; stimulate steroidogenesis; [238–240]
FGF4 Embryonic lethal Sertoli cells Enhance spermatogenesis [241–243]
HGF Embryonic lethal Spermatozoa, myoid cells Initiate sperm motility, induce testicular cord formation [244–246]
MIF Viable/fertile Leydig cells Leydig-Sertoli cell paracrine mediator/inhibit
inhibin production
[247,248]
SCF Perinatal lethal (/),
sterile (+/)
Sertoli cells (c-Kit receptor
on differentiating spermatogonia)
Spermtogenesis; Sertoli cell-spermatogonia adhesion
(membrane bound form)
[11,249,250]
VEGF (A) Embryonic lethal (+/) Sertoli cells (receptor on germ cells),
Leydig cells
Spermatogonial proliferation, spermiogenesis [251–253]
Interleukin/interferon IL-1a/-1b Viable/lowered fecundity Sertoli cells, spermatocytes, spermatids Inhibit steroidogenesis, Regulate Sertoli secretion [254,255]
IFN-g Viable/fertile Spermatogonia, interstitium Inhibit steroidogenesis, stimulate FasL expression [256,257]
Abbreviation: bone morphogenetic protein (BMP), epidermal growth factor (EGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF, or scatter factor, SF), interferon (IFN), interleukin (IL),
macrophage migration inhibitory factor (MIF), Stem cell factor (SCF, or Steel factor, SLF), transforming growth factor b (TGF-b), tumor necrosis factor a (TNF-a), tumor necrosis factor-a-related apoptosis-
inducing ligand (TRAIL), vascular endothelial growth factor (VEGF).
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stream of TNF, at least 19 ligands and more than 20
receptors have been identified in the TNF superfamily [103],
which can mediate an array of physiological processes and
diseases [103]. It has been known that TNF can disrupt TJ
integrity in multiple epithelial cells. As aforementioned,
TNF down-regulates occludin expression through its
promoter activity [55] or reduces JAM-A distribution on
the vascular endothelial cell surface [38]. TNF level is also
elevated in Crohn’s disease, a chronic granulomatous
inflammatory disease that affects the gastrointestinal tract,
which is manifested by impaired intestinal barrier function
with leaky TJs [105]. With the exception of TNF and Fas
ligand (FasL), the roles of other members of TNF superfamily
in the testis remain elusive.
In the testis, TNFa has been shown to play a role in
regulating germ cell apoptosis, junction remodeling and
Leydig cell steroidogenesis [57,106,107]. For instance, it is
known that TNFa represses the expression of steroidogenic-
enzyme genes in Leydig cells through an activation of
NFkB, which can in turn inhibit the transactivation of
orphan nuclear receptors [106]. Intratesticular injection of
TNF in normal and hypophysectomized rats has also
demonstrated its suppressive effect on testosterone produc-
tion in vivo [108]. Chronic infusion of TNF caused germ cell
(in particular spermatocytes and spermatids) depletion from
the epithelium, a loss of testis weight and a plunge in
testosterone level [58]. It remains unknown regarding the
mechanism(s) by which TNFa utilized to induce these
changes, but this could involve a suppression of Leydig cells
steroidogenesis, or an inhibition of Sertoli cell TJ protein
production at the BTB, or via its direct effect on germ cells.
Other recent studies have shown that TNFa can perturb the
TJ-permeability barrier in cultured Sertoli cells dose-
dependently and reversibly since the disrupted TJ-barrier
can be resealed upon the removal of the cytokine [57]. This
inhibitory effect of TNFa on Sertoli cell TJ function is likely
mediated via an induced production of collagen a3(IV),
matrix metalloprotease (MMP)-9 and tissue inhibitor of
metalloprotease (TIMP)-1 which collectively affect the
homeostasis of ECM, thereby altering the association of the
Sertoli cell epithelium with the basement membrane and
perturbing the TJ-barrier [57]. Also, TNFa can activate the
integrin/integrin linked kinase (ILK)/glycogen synthase
kinase (GSK) b-3/p130 Cas/JNK signaling pathway which
also contribute to changes in the TJ-protein expression and/
or distribution at the BTB [22,57,97].
3.2. TGF-b
The TGF-b superfamily comprises of TGF-bs, activins,
inhibins, bone morphogenetic proteins (BMPs), growth
differentiation factors (GDFs), Mu¨llerian-inhibiting sub-
stance (MIS) and others, totaling more than 35 members
[109]. TGF-b superfamily proteins are crucial in the
regulation of a variety of biological processes, including
cell proliferation, differentiation, apoptosis, and tissue
remodeling [110]. Some members, like activins and
inhibins, were initially identified in the male gonad for
their ability to regulate the pituitary follicle stimulating
hormone (FSH) production [11]. MIS is known for its role in
sexual differentiation causing the regression of the
Mu¨llerian ducts in the male [111]. The functions of TGF-
b superfamily proteins in reproduction have been recently
reviewed [109,112] hence we only focus on regulation of
junction restructuring by TGF-bs herein, which is elabo-
rated in Section 4. Table 2 summarizes other cytokines that
are known regulators of junction dynamics.
3.3. Cytokines working in concert with other ECM
proteins to regulate junction dynamics
Recent reviews have summarized how cytokines regulate
the homeostasis of proteases and their inhibitors, and ECM
proteins to coordinate spermatogenesis [2,22,97]. It is not at
all surprising that these molecules are working in concert
since their production, activation, and termination are all
interdependent and connected. Their homeostasis and
regulation are essential to almost all biological processes.
In the testis, for instance, when the BTB is disrupted by
cadmium, TGF-b3/p38 MAPK signaling is activated to
down-regulate the steady-state of TJ and AJ protein levels
that leads to the breakdown of both junctions and germ cell
exfoliation [44,52,113]. Proteases (e.g., cathepsin L) and
protease inhibitors (e.g., a2-macroglobulin) are induced to
coordinate the junction restructuring event [52]. Using a p38
MAPK inhibitor SB202190, the damage to the BTB and the
plunge of TJ and AJ proteins induced by CdCl2 can be
delayed but it cannot prevent the overexpression of protease
inhibitor a2-MG [52]. Further study revealed that a2-MG
production is regulated by JNK signaling pathway in the
testis, independent of the p38 MAPK pathway [114]. This
yin and yang relation of protease and protease inhibitor
regulation that utilizes distinct signaling pathways, and their
connection with cytokines (e.g., TGF-b3) have illustrated
that the testis is equipped with some delicate regulatory
mechanisms to orchestrate junction restructuring at sper-
matogenesis.
4. TGF-b3 as a junction regulator—versatility
realized through selectivity
4.1. Signaling conduits and versatile players in
biological processes
TGF-bs (b1, b2 and b3) are key regulators in a plethora
of biological processes (for reviews, see [110,115–120]).
These cytokines, when activated by releasing from the
latency-associated proteins (LAPs), can bind to their
receptors—first to the type II receptor, TbRII, which then
recruits the type I receptor, TbRI (or ALT5, activin-like
kinase)—although TGF-b2 requires binding of the two
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receptors more or less at the same time and the assistance
from the type III receptor, betaglycan. The binding of the
cytokine to type I and type II receptors initiates a series of
phosphorylation mediated activation—autophosphorylation
of TbRII and TbRI phosphorylation by TbRII—and triggers
consequent intracellular signaling events (the canonical
Smad-mediated signalings and Smad-independent path-
ways). Despite their structural similarities and shared
signaling mechanisms, the three TGF-bs are spatiotempo-
rally expressed and play non-redundant roles, particularly
under in vivo conditions. This in part is attributed to their
unique promoter sequences [121]. For instance, in the mouse
testis, expression of TGF-b1 and TGF-b2 are much higher
in embryonic and early postnatal stages, and TGF-b3
becomes the highest expressed among the three isoforms in
adulthood [122]. Similarly, in postnatal day 5 to day 60 rats,
TGF-b1 and TGF-b2 expression are predominant in
immature testes, which decrease at the onset of puberty;
whereas TGF-b3 expression is most abundant at the pubertal
stage, coinciding with the initiation of spermatogenesis
[123]. These thus illustrate TGF-bs have unique roles in
distinct phases of testicular development: TGF-b1 and TGF-
b2 are important for the development while TGF-b3 takes
the center stage during spermatogenesis. Herein, we
summarize the TGF-b-mediated signaling conduits, focus-
ing on their regulation of junction remodeling.
4.1.1. Smad-mediated signaling
The smad-mediated TGF-b signaling pathways have
been extensively characterized and recently reviewed
[110,116,124,125]. Among the 8 Smad proteins (Smad1–
8), receptor-regulated R-Smad (Smad2 and Smad3),
common-partner Co-Smad (Smad4) and inhibitory I-Smad
(Smad 7) are involved in TGF-b/TbRII/TbRI signaling.
However, many of these Smad proteins have not been
subjected to rigorous investigation in the testis. In the testis,
the expression of Smad2 and Smad3 are developmentally
regulated and stage-specific: being more prominent in
prepubertal than in sexually mature rats, and at the lowest
levels at stages VII–VIII of the epithelial cycle in adult rats
[126]. Expression of Smad3, 4, 6 and 7 are also detected in
embryonic mouse testes [127]. It is not surprising that Smad
proteins are highly expressed in younger animals since TGF-
b superfamily members are essential for development. TGF-
b1 and TGF-b2 may be more important in the testis at the
early stages through Smad-mediated signaling pathways.
Yet the regulation and maintenance of spermatogenesis by
TGF-b3 in adult testes is likely mediated via Smad-
independent signalings, such as TJ and BTB dynamics [68].
For instance, TGF-b3 activates ERK without activation of
Smad2 and Smad3 in the Adjudin-induced germ cell loss
model [68].
4.1.2. MAPK-mediated signaling
There are accumulating evidence in the literature
regarding Smad-independent TGF-b signalings that regulate
diverse biological function, which has recently been reviewed
[115,116,118,128]. Amongst these, the best studied is the
MAPK signalings [129–131]. For instance, TGF-b is capable
of activating all three MAPK pathways [115,118,125]. In the
testis, all three pathways have been implicated in the
regulation of junction dynamics pertinent to spermatogenesis.
First, JNK pathway is involved in TNF-a-induced TJ
restructuring and a2-MG regulation [57,114]. Second, ERK
pathway can be activated via either integrin or TGF-b3, which
can in turn regulate AJ dynamics [36,37,68]. Third, p38
MAPK is responsible for TGF-b3-activated TJ and AJ
restructuring [52,113,132]. Nonetheless, little is known about
the expression and distribution of MAPKs and their upstream
kinases in the testis. ERK1/2 and p-ERK1/2 have been
localized to the elongate spermatids at the apical ES/TBC site
in the epithelium at stages VII–VIII [68,133], illustrating its
role in spermiation. ERK1/2 is also detected at the basal
compartment of the epithelium [133]. Indeed, when induced
by Adjudin, p-ERK1/2 is activated at the site of apical ES in
depleting elongate/elongating spermatids in tubules other
than stages VII–VIII, probably facilitating germ cell
exfoliation [68].
The complexity of TGF-b-mediated signaling pathways is
manifested by the presence of multiple intracellular inter-
acting points. Recent studies have identified different
interacting proteins with TGF-b receptors, illustrating these
proteins may play a role in selecting the downstream signaling
events. For example, occludin is known to associate with
TbRI and as such, TGF-b can efficiently regulate TJ
disruption during epithelial-mesenchymal transition (EMT)
[134]. Indeed, the proximity of TGF-b receptors with TJ
proteins has created an efficient regulatory mechanism where
TGF-b-induced TJ dissolution is mediated through the cell
polarity complex. Upon activation by TGF-b, TbRII is
recruited to the TbRI/occludin/Par6 complex, thereby
phosphorylating Par6, this in turn stimulates Par6 which
binds to Smurf1 (an E3 ubiquitin ligase), and causing
degradation of RhoA that leads to TJ disassembly [135,136].
Although it has not yet been confirmed for TbRII, proteins
that associate with type II receptor of BMP have recently been
identified, which include MAPK, PKC, and cytoskeleton
tubulin b5 [137]. These proteins associate not only with the
kinase domain of the receptor but also its C-terminus [137],
illustrating receptors of the TGF-b family proteins can affect
junction dynamics via protein-protein interactions with
junction protein complexes.
4.1.3. TGF-bs regulate junction restructuring
TGF-bs regulate junction dynamics in various cell types.
For instance, TGF-b1 can perturb the permeability of the
blood–retinal barrier via a stimulation of MMP-9 production
[138]. TGF-b1 also perturbs the TJ-permeability barrier in
pulmonary endothelial monolayers by inducing AJ proteins
to move away from the cell–cell contact site, possibly via a
myosin light chain kinase mediated mechanism [139]. TGF-
b1 and Ras can also work synergistically to promote cell
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invasiveness in intestinal epithelial cells by down-regulating
E-cadherin expression and subcellular redistribution of b-
catenin [140]. In addition, TGF-b1 can induce AJ disruption
in renal proximal tubular epithelial cells, which cannot be
reproduced by transient overexpression of Smad2/4 or
Smad3/4 [141], illustrating this is an Smad-independent
signaling event. On the other hand, a blockage of TGF-b
signaling by treatment of a TGF-b receptor kinase inhibitor
up-regulates TJ protein production (e.g., claudin-5) in
embryonic stem cell-derived endothelial cells [142].
Interestingly, in almost all of these epithelial/endothelial
cells, a disruption of either TJ or AJ can affect the integrity
of the other junction type following an induction by TGF-bs.
Yet the functional inter-relationship of AJ and TJ in the
seminiferous epithelium is significantly different from all
other epithelia and endothelia. For instance, TGF-b3 (and
also TGF-b2 in vitro) can disrupt the Sertoli–Sertoli TJ-
barrier by down-regulating TJ proteins (e.g., occludin) via
p38 MAPK signaling pathway and this effect is indeed
confirmed using an in vivo model to study the BTB
dynamics [44,113,132] (see Fig. 2). Analogous to other
epithelia and endothelia, a breakdown of TJ can indeed
affect the integrity of AJ, resulting in a loss of Sertoli–germ
cell adhesion [52]. However, a disruption of AJ between
Sertoli–germ and Sertoli–Sertoli cells seems to reinforce the
TJ at the BTB instead, let alone its disruption, in the
Adjudin- and intratesticular testosterone suppression-
induced germ cell loss models [2,30]. Recent studies have
shown that TGF-b3 can exert its effects on AJ integrity via a
signaling pathway different from the one that regulates TJ
dynamics in the testis [68], so that Sertoli–germ cell AJ can
undergo restructuring without perturbing the BTB integrity
(Fig. 2). This unique relation of AJ and TJ in the
seminiferous epithelium may be a physiological require-
ment for the testis to facilitate germ cell migration (i.e., AJ
restructuring) while maintaining TJ integrity. This concept
will be revisited and discussed in detail in Section 5.
4.2. Signaling regulation and selectivity
4.2.1. Multilayers of signal modulation
Regulation of TGF-b-mediated signalings occurs at
multiple levels: ligand production and activation, ligand–
receptor coupling, intracellular signal pathway selection,
nucleocytoplasmic shuttling of transcription factors, an
interaction of multiple transcription factors that finally
determines the activation or repression of gene expression,
and signal termination [110,143–146]. Less is known
regarding how the expression of TGF-bs is regulated. The
promoter sequences of human TGF-bs have been char-
acterized. For instance, TGF-b1 is mostly regulated by AP-1
site lacking TATA box, whereas TGF-b2 and TGF-b3 are
regulated by AP-2 site and cAMP-responsive elements,
containing TATA box [121], and the most potent activator of
TGF-b1 expression known thus far is the cytokine itself
[147]. It has been shown that JNK suppresses the autocrine
expression of TGF-b1 in fibroblasts [148]. A recent in vivo
study in the testis has shown that JNK signaling is required
for the production of a2-MG in the seminiferous epithelium,
which tethers TGF-b3 and antagonizes the cytokine [114].
These results thus illustrate the TGF-b action is regulated at
multiple levels and can induce diversified biological
responses. Upon secretion, TGF-bs are tightly but non-
covalently bound to LAPs, which are further tethered to
latent transforming growth factor-b binding proteins
(LTBPs) via covalent bonds [149]. LTBP can covalently
bind to ECM, enabling cytokines to be retained in the matrix
and creates a reservoir [149]. This biologically inactive
cytokine pool can be activated by low pH, protease (e.g.,
plasmin, MMP-2 and MMP-9), thrombospondin-1 (TSP-1),
integrin-avb6 or -avb8 [145,146,149,150]. At least one
LTBP called LTBP-1L (long form) is highly expressed in
testes [150]. MMP-2 and MMP-9 are also found in the testis
[97]. Other antagonists of TGF-bs include a2-MG and
decorin, which can ‘lock’ the ligand and prevent its binding
with receptors, and endoglin, which binds to TbRII-
associated TGF-b1 or -b3 and attenuates TbRI mediated
signaling [110,151,152]. After TGF-b binds to its receptors,
signaling is triggered but can be directed to a distinctive
pathway, and can sometimes activate multiple pathways.
Because of such diversified signaling capacity, a mechanism
must be in place to choose the needed downstream signaling
pathway. It is likely that adaptor proteins play the decision-
making role. For instance, activation of Smad2/3 is
facilitated by the adaptor SARA. Yet the detail of this
selection still remains elusive. To transmit the signaling to
the corresponding genes for their transcriptional induction,
activated transcription factors (e.g., Smad2 and Smad3)
must enter the nucleus. As such, there is constant
nucleocytoplasmic shuttling of the R-Smads between active
(phosphorylated) and inactive (dephosphorylated) status to
keep sensing the signals at real-time [110,144]. The cell-
specific and non-specific transcription factors/coactivator/
co-repressors can determine the final gene expression
outcome in a particular cell type at the end of TGF-b
activation [110,116]. Receptor internalization and degrada-
tion, Smad shuttling and ubiquitination, and expression
feedback can all contribute to the signal termination [118].
4.2.2. Adaptors as molecular switches for TGF-b
signaling in the testis
It is of interest to note that in the testis, the TGF-b3-
activated signaling can have distinctive effects on the
junction restructuring. When p38 MAPK is activated by
TGF-b3, the BTB in the seminiferous epithelium is
disrupted concomitant with Sertoli–germ cell AJ disas-
sembly [52] (Fig. 2). In contrast, when ERK1/2 is activated
by TGF-b3, only AJs are affected without affecting the BTB
integrity [68] (Fig. 2). Indeed, a blockade of the TGF-b3-
mediated signaling by using an antagonist (e.g., TbRII/Fc
conjugate) can prevent the activation of ERK1/2 and
significantly delay the Adjudin-induced germ cell loss from
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Fig. 2. A schematic illustration of how cytokines (e.g., TGF-b3, TNFa) can regulate junction dynamics in the testis via their effects on the steady-state levels of
proteins (e.g., TJ- and AJ-proteins, protease inhibitors such as a2-MG) at the BTB and apical ES. This model was prepared based on recent studies from this
laboratory using different animal models as reviewed herein. In brief, cytokines released from either Sertoli or germ cells can activate at least three different
signaling pathways upon their binding to receptors. For instance, TGF-b3 can activate p38 MAPK signaling pathway to down-regulate both TJ and AJ proteins,
resulting in the disruption of the BTB and Sertoli–germ cell adhesion function, eventually leading to germ cell loss from the epithelium (green sector), which
was identified in studies using the cadmium model [52,113,132]. This also illustrates that when TGF-b3 utilizes the p38 MAPK pathway for its signaling
function, it can perturb both the BTB and apical ES integrity. When rats were treated with Adjudin, or testosterone/estradiol implants to reduce intratesticular
androgen level, the testis responds to these treatments with an induction of TGF-b3 that can activate only the ERK signaling pathway to compromise Sertoli–
germ cell adhesion function by lowering the steady-state protein levels at the apical ES or weakening protein-protein interactions at this site via changes in the
phosphorylation status of adaptors (e.g., b-catenin); this in turn leads to the loss of germ cells from the epithelium, and this event does not affect the BTB
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the epithelium [68]. By blocking these two MAPK signaling
pathways using kinase inhibitors can also rescue the
epithelium from the disruptive effects of CdCl2 and Adjudin
on the BTB and Sertoli–germ cell AJ, respectively
[52,68,113]. As such, TGF-b3 serves as a key regulator
that decides whether BTB is affected or not. It is tempting to
speculate that this TGF-b-activated MAPK signaling
cascade requires the recruitment of adaptors to the site
which can in turn shuttle to the correct signaling pathway
downstream. Recent studies have shown that TGF-b-
induced p38 MAPK activation is mediated through a protein
scaffold complex XIAP (X-linked inhibitor of apoptosis)/
TAB1 (TAK binding protein)/TAK1 (TGF-b-activated
kinase), in which adaptor XIAP may link adaptor TAB1
and MAPKKK TAK1 to the TbRI. TbR1 can activate
TAK1, which further activates either MKK3/6 or MKK4 that
in turn activates p38 MAPK or JNK, respectively [118].
Besides, MAPKK-independent autophosphorylation of p38
is also possible, which is TAB1 dependent [153]. On the
other hand, TGF-b can activate Ras, which further activates
ERK signaling pathway and regulates various cellular
processes including junction dynamics [68]. TGF-b-induced
ERK activation also requires the adaptor CD2-associated
protein (CD2AP). When this adaptor is not involved, p38
MAPK is preferentially activated instead. In its presence,
TGF-b activates both the PI 3-kinase/Akt and the Ras/ERK
pathways [154]. Interestingly, CD2AP is not involved in PI
3-kinase/Akt activation by EGF and insulin, nor in the
activation of Smad2 by TGF-b, suggesting it plays a role in
TGF-b-activated, Smad-independent signaling [155]. The
association between TGF-b receptors and CD2AP is further
supported by the evidence that both are present in lipid rafts
[156,157]. Thus CD2AP can serve as a molecular switch to
determine the downstream signaling direction of TGF-b.
CD2AP belongs to a family of ubiquitously expressed
adaptors containing three Src-homology 3 (SH3) domains, a
proline-rich region and a coiled-coil domain [158] and is
expressed in human testes [159]. The SH3 domain mediates
interaction with the p85 subunit of PI 3-kinase and the
proline-rich region mediates association with p130 Cas and
Src family kinases (for a review, see [158]). p130 Cas and
Src are components of a signaling machinery connecting
FAK, paxillin, ERK and myosin light chain kinase (MLCK),
which, in turn regulate cell adhesion during cell migration
process [160]. Interestingly, virtually all of these proteins
have recently been found in the testis and they are likely
involved in junction dynamics during spermatogenesis (for
reviews, see [2,22,97]). It is likely that CD2AP is a crucial
adaptor of TGF-b mediated and integrin/FAK mediated
signaling events in the testis. Although much of the
information on CD2AP derives from studies in the kidney,
the testis may employ this molecular switch to select the
downstream signaling pathways to be activated by TGF-b3,
affecting either AJ alone or TJ and basal ES at the BTB. This
should be vigorously validated in future studies.
5. What lessons we learn from the testis as a model to
study junction restructuring?
As we have discussed above, the testis is an intriguing
organ where extensive junction restructuring occurs in the
seminiferous epithelium at each stage of the epithelial cycle.
Recent studies aiming to delineate the mechanisms that
regulate the junction restructuring events in the testis have
yielded some crucial information, which is likely applicable
to general cellular physiology as a whole. Herein, we
summarize several in vivo models that have been established
and used in recent studies (see Table 3). We only highlight
some of the latest development using these models and
readers are encouraged to refer to several recent reviews
[1,2,9,75,161,162].
5.1. Adjudin model
Formerly called AF-2364 [1-(2,4-dichlorobenzyl)-1H-
indazole-3-carbohydrazide], Adjudin is a molecule that
selectively induces adherens junction disruption. It is a well
studied potential male contraceptive derived from indazole-3-
carboxylic acid [163,164]. It is also one of the best studied
compounds that induce germ cell sloughing in the testis.
Adjudin apparently exerts its effects on the Sertoli–germ cell
adhesion unit to induce a loss of AJ function by triggering a
couple of signaling events, including a surge of the ES-
associated signaling molecule testin, an induction of integrin-
and cadherin-initiated pathways, as well as TGF-b3 activa-
tion [37,66–68,74,163,165–167]. Moreover, the ES-based
AJs are compromised due to a loss of protein-protein
association in the N-cadherin/b-catenin and nectin/afadin
protein complexes, which is likely the result of a coordinated
regulation by protein and lipid kinases and phosphatases,
proteases and protease inhibitors [35,67,68,74,94]. These
signalings are triggered within a few hours after adult male
rats are treated with a single or multiple doses of Adjudin at
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integrity (blue sector) [2,68]. This thus suggests that TGF-b3 can limit its action at the apical ES without compromising the BTB when the ERK signaling
pathway is being utilized. Using the cadmium model, it is presently known that JNK is activated during the cadmium-induced BTB damage. This induces the
production of a2-MG, which either bind to the free cytokines, limiting their biological action and/or blocking protease activity to limit the BTB damage. Since it
is known that by blocking the production of a2-MG, it can worsen the damaging effect of cadmium on testicular junctions (red sector), illustrating this JNK-a2-
MG pathway is crucial to maintain the normal physiology in the seminiferous epithelium [57,114]. This pathway is likely utilized by TNFa to regulate the
steady-state protein level of a2-MG. The coordinated action of these three interacting signaling pathways that are intriguingly regulated by cytokines (e.g., TGF-
b3 and TNFa) is crucial to maintain the integrity of the seminiferous epithelium during spermatogenesis, permitting selective disruption of either TJ, AJ, or TJ
and AJ. As reviewed herein, it is likely that adaptors play a crucial role upstream to select which signaling pathway should be activated by these cytokines, which
in turn determines if either BTB, apical ES, or both BTB and apical ES should be compromised during spermatogenesis.
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40–50 mg/kg b.w. either via i.p. or by gavage. Thereafter,
morphological changes (i.e., germ cell depletion) are typically
seen by 6–8 h [168]. The effect of Adjudin is limited to AJs,
since the BTB remains intact in Adjudin treated rats.
Furthermore, spermatogonia cell population apparently is
unaffected [2]. Its antifertility effects are reversible, since the
voided tubules treated with Adjudin can become repopulated
with germ cells, making them almost indistinguishable from
normal testes [164]. Studies from Adjudin treated rat testes
have revealed some regulatory mechanisms that affect
Sertoli–germ cell adhesion function pertinent to spermato-
genesis. For instance, the integrin/FAK signaling is activated
during Adjudin-induced germ cell loss from the epithelium
[37]. This information has recently been validated and
expanded using an androgen suppression-induced germ cell
loss model in which rats received androgen and estrogen
implants to suppress the intratesticular androgen level thereby
perturbing Sertoli–germ cell apical ES function [36,37]. More
important, TGF-b3 is also induced in androgen-suppressed
rat testes, similar to the Adjudin model ([68] and unpublished
observations), illustrating the involvement of cytokines in cell
adhesion function. It is possible that the migration of germ
cells across the seminiferous epithelium during spermatogen-
esis is controlled by several independent signaling pathways.
When an agent activates these signalings, though the initial
responses are different for different agents, the net outcome
(i.e., alteration in Sertoli–germ cell adhesion function and the
subsequent germ cell sloughing) is similar. Indeed, the
signaling events in the rat testis identified using the Adjudin
model have shown that this organ is utilizing the junction
restructuring events usually restricted cell-ECM interface to
regulate cell adhesion, migration, tissue remodeling and
development, and tumor cell metastasis [115,169,170],
illustrating the cell–cell anchoring junction in the testis is
indeed a hybrid cell–cell and cell–matrix junction type [22].
5.2. Cadmium model
Cd is a heavy metal and an environmental pollutant that is
widely used in industry. It poses significant threat to human
health and is classified as an endocrine disruptor [171–173].
It adversely affects a number of organs including the testis,
kidney, lung, liver, pancreas and placenta [171,173]. The
molecular mechanisms of action of cadmium toxicity are
rather diverse which include: (i) binding to estrogen
receptors, mimicking estrogen in the uterus and mammary
gland [174]; (ii) disrupting the cadherin-based cell–cell
adhesion [172]; (iii) inhibiting the DNA mismatch repair
[175]; and (iv) disrupting endothelial and blood-testis
barriers [52]. The testis is very sensitive to Cd exposure and
the Cd-induced testicular effects (e.g., necrosis) is common
across all animal species [176]. The antifertility effect of Cd
has been known for decades. A recent study has identified a
metal transporter of Cd (ZIP8, ZRT-, IRT-like protein 8) that
is highly expressed in Sertoli cells [176], which likely
explains, at least in part, why this cell type is sensitive to Cd-
induced damages in the testis. Indeed, the junctional proteins
are the early targets of a panel of toxicants, including Cd, in
Sertoli cells cultured in vitro [177]. At a relative low dosage
of Cd (e.g., 0.1–1 mM), it can reversibly perturb the Sertoli
cell TJ-barrier in vitro when testosterone and FSH are
present in the media [178]. Intraperitoneal administration of
cadmium (1–3 mg/kg b.w.) to adult rats can irreversibly
damage the BTB, which has been used as a model to study
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Table 3
Chemicals that target the testis and can potentially serve as models to study junction dynamics
Affectedjunction
types
Chemical Classification Target junction types in the testis and
manifestations
References
TJ/AJ Cadmium Heavy metal BTB/ES disruption; germ cell loss/apoptosis,
irreversible
[52,114,178,179,200]
TJ Cisplatin Chemotherapeutic drug BTB disruption; azoospermia, irreversible [177,258,259]
TJ Glycerol 1,2,3-Propanetriol BTB disruption; germ cell loss, irreversible [260,261]
TJ Occludin peptide 22-a.a. from 2nd extracellular
loop of occludin
BTB disruption; germ cell loss, reversible [262]
AJ/TJ Gossypol Extract from cotton seed oil ES/AJ/prevent BTB formation in neonatal animal;
germ cell loss; irreversible in neonatal animal
[177,263–265]
AJ Adjudin (AF-2364) Indazole-3-carboxylic
acid analog
ES/AJ disruption; germ cell loss, reversible [163,164]
AJ AF-2785 ES/AJ disruption; germ cell loss, reversible [163,164]
AJ Lonidamine (AF-1890) ES/AJ disruption; germ cell loss; irreversible
in selected subjects
[266]
AJ Testosterone/estrogen
implants
Steroid hormone ES/AJ disruption; germ cell loss, reversible [30,33,35,36,267,268]
AJ Vinclozolin Fungicide/antiandrogen ES/AJ (?); germ cell apoptosis [180,191,269,270]
AJ Phthalate Widely used as a plasticizer
and in cosmetics/antiandrogen
Basal and apical ES disruption; seminiferous
tubule atrophy, germ cell loss
[180,181,183,186]
AJ Bisphenol A Plastics/estrogenic Apical ES disruption; abnormal spermatids,
acrosomal defects
[177,182,198,271–273]
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BTB dynamics in the testis [52,113,114,179]. Apparently,
when absorbed by Sertoli cells, Cd targets the microfila-
ment, causing a disorganization of actin bundles [179].
Furthermore, Cd induces the dissolution of TJ proteins (e.g.,
occludin) from the seminiferous epithelium, and down-
regulates AJ-proteins (e.g., cadherin, nectin) to induce a
secondary disruption of basal ES, leading to germ cell
sloughing [52]. Using this model, it has been shown that the
TGF-b3/MEKK/p38 MAPK mediated signaling pathway is
a putative mechanism that regulates TJ dynamics at the BTB
in vivo, and a disruption of this pathway using specific
inhibitors can indeed significantly delay the Cd damage to
the BTB as well as the subsequent germ cell loss from the
epithelium [44,113,132].
5.3. Possible in vivo models to study junction dynamics
in the testis
Recent studies have illustrated a number of chemicals
that can affect testicular junctions, which may be developed
into useful in vivo models. Many of these molecules are
endocrine disruptors, which include phthalate, bisphenol A,
vinclozolin and others [180–183]. Because of their wide-
spread distribution in the environment and potential health
hazards (e.g., reproductive organs), these compounds have
attracted great attention of research, particularly on their
effects to the reproductive organs (e.g., testes). They affect
the endocrine system either by acting as antiandrogens
(e.g., phthalate, vinclozolin) or estrogens (e.g., bisphenol A)
[180–183].
Phthalate and vinclozolin are compounds that can
antagonize androgens. However, they exert these effects
via different mechanisms: phthalate affects androgen
synthesis [183] whereas the metabolites of vinclozolin are
antagonists of androgen receptors [184,185]. Phthalate is
found in cosmetic products (e.g., nail polishes, perfumes,
hair sprays) and is widely used as a plasticizer, which can be
non-covalently bound to the matrix and thereby slowly
releases to the environment, and can be inhaled or adsorbed
dermally [181,183]. Its toxic effects in male neonatal
animals include hypospadias, reduced anogenital distance,
vaginal pouch, some of which (e.g., hypospadias) are
detected in humans [180,181,183,186]. When adults rats
were treated with a single dose of di-n-pentyl phthalate
(DPP) (2.2 g/kg b.w.), Sertoli cell junctions displayed
abnormalities with disrupted basal ES, and apical ES was
either absent or badly disorganized [187]. Interestingly, the
disrupted basal ES between apposing Sertoli cells were
reformed by 48 h after DPP treatment [187], illustrating this
is a potentially useful model to study basal ES dynamics if
adequately characterized. Furthermore, in DPP-treated
prepubertal rats, extensive vacuolation occurs in Sertoli
cells, to be followed by sloughing of germinal cells [188].
Apparently the observed effects of phthalate on germ cell
loss are mediated via disruption of Sertoli-Sertoli and
Sertoli–germ cell adhesion function.
Vinclozolin [3-(3,5-dichlorophenyl)-5-methyl-5-viny-
loxazolidine-2,4-dione] is a fungicide that is widely used
in farming industry. When adsorbed by humans or rodents,
vinclozolin is metabolized to M1 (2-[[(3,5-dichlorophenyl)-
carbamoyl]oxy]-2-methyl-3-butenoic acid) and M2 (30,50-
dichloro-2-hydroxy-2-methylbut-3-enanilide), which can
bind to androgen receptors, antagonizing androgen function
in vivo [184,185]. Besides its disruptive effects on
reproductive organs (e.g., hypospadias, reduced anogenital
distance) in male rats when exposed to vinclozolin in utero, it
is neurotoxic and is an endocrine disruptor [189]. In the testis,
vinclozolin can induce Leydig cell hypertrophy, reduce testis
weight as a result of germ cell loss, and subsequently impair
sperm production [190–192]. The direct structural damage of
junctions at the Sertoli–Sertoli and Sertoli–germ cell interface
following vinclozolin treatment remains to be examined.
Bisphenol A is a xenoestrogen although its bioactivity is
1000–1500-fold lower than 17b-estradiol. An ultrastructural
examination of adult rat and mouse testes after treatment
with bisphenol A has revealed that the apical ES was absent
or badly damaged versus control animals; but, interestingly,
the basal ES and BTB were not affected [182]. This
information has also strengthened the notion that AJ
disruption in the seminiferous epithelium can be restricted
to the ES site without perturbing the TJ-barrier function at
the BTB [2,30] in contrast to other epithelia where a
disruption of AJ can lead to a secondary damage of the TJ-
barrier function and vice versa [193–197]. The disruptive
effects of bisphenol A and estrogens (17B-estradiol and b-
estradiol-3-benzoate) on apical ES (but not basal ES and
BTB, which remained intact) was also detected in
maturating rats and mice that had been exposed to bisphenol
A at neonatal [198]. However, these effects were not found
when rats were fully mature [198]. In short, one of the target
structures of this endocrine disruptor is the apical ES.
5.4. Why is the testis a vulnerable target of
environmental toxicants? A lesson to learn from the
testis
Studies on different environmental toxicants have
unequivocally demonstrated that the testis is extremely
vulnerable to these toxicants (for a review, see [199]). When
exposed to these chemicals, Sertoli-Sertoli and Sertoli–germ
cell junctions are the early targets and their subsequent
dissolution is likely the result of down-regulation of junction
proteins or changes in protein-protein association of the
junction protein complexes [177]. Indeed, recent studies
have shown that when adult rats were exposed to cadmium
chloride, the BTB damage had occurred at least 24 h before
the TJ-barrier of the microvessel in the interstitium
[114,200], indicating the BTB is more sensitive than the
endothelial TJ-barrier in microvessels to cadmium toxicity.
Subsequent analyses by immunohistochemistry and fluor-
escent microscopy using these rats have conclusively
demonstrated a significant loss of TJ- and AJ-integral
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proteins from the BTB site, consistent with results of
immunoblot analyses [52,114]. Furthermore, a loss of
protein-protein interactions of the AJ integral membrane
proteins and their adaptors namely cadherin-catenin and
nectin-afadin was also detected when rats were exposed to
Adjudin [68], a chemical known to induce germ cell loss
from the seminiferous epithelium without disrupting the TJ-
barrier at the BTB (for reviews, see [1,2,9]). Taking
collectively, these data have clearly illustrated the vulner-
ability of the testis to environmental toxicants (e.g.,
cadmium) and that the proteins at the TJ and AJ sites are
some of the primary targets of these toxicants. While the
precise mechanism underlying such vulnerability is not fully
understood, recent studies have shed new lights on this issue,
which also highlights a unique opportunity to use these
toxicant-induced BTB or AJ damage to the testis as novel
models to study BTB dynamics, AJ restructuring pertinent to
spermatogenesis, and their regulation. Furthermore, these
studies can plausibly provide new insights in developing
preventive measures to antagonize these toxicants.
First, Sertoli cells are secretory cells that actively provide
virtually all the necessary nutrients for germ cell develop-
ment behind the BTB including metal transporters, such as
transferrin, ceruoplasmin, and metallothioneins (MTs). MTs
are small Mr proteins having high affinities for heavy metal
ions including cadmium, zinc, copper and mercury. MTs are
produced in virtually all mammalian tissues in response to
metal ions exposure, which can detoxify heavy metals, such
as cadmium (for reviews, see [201,202–205]). MTs are also
important to maintain the homeostasis of essential trace
elements, such as zinc and copper and are scavengers of free
radicals [202,204] and protect cells from the cytotoxic
effects of cadmium [206]. In the rat testis, MTs, such as MT1
and MT2, have been identified and isolated [207,208].
Recent studies have found a novel testis-specific MT-like
protein called tesmin which is specifically expressed by
spermatogenic cells [209]. MT1 and MT2 are products of
Sertoli and germ cells, which are significantly induced after
cadmium exposure [210]. Yet the production of MTs by
Sertoli and germ cells are significantly lower when
compared to hepatocytes in vitro in response to cadmium
exposure [210]. Indeed, the quiescence of MT expression in
the ventral prostate and the testis is the possible cause of
their susceptibility to cadmium cytotoxicity and carcino-
genicity [204,211–213].
Second, recent studies on the effects of cadmium on
different cell lines, including MDCK, LLC-PK1, and Caco-2
cells, have shown that its primary target is E-cadherin (for a
review, see [214]). For instance, cells that were exposed to
cadmium were found to have their E-cadherin moving away
from the cell–cell interface and became diffusely localized
in the cytoplasm. It was postulated that cadmium may be
competing to the binding of calcium to the E-cadherin,
thereby perturbing the AJ function [214–217]. If this is the
case, cadmium (and possibly other environmental toxicants)
must first gain access to AJ to disrupt E-cadherin. In all other
epithelia found in mammals, AJ is physically located behind
the TJ since the TJ-barrier is located to the apical portion of
the cell epithelium, and behind TJ lies desmosomes, which
collectively known as the junctional complex. Behind the
junctional complex are the gap junctions to be followed by
the cell–matrix adhesion complex. As such, the TJ would
seal most of the environmental toxicants off the epithelium
in virtually all organs. Yet in the testis, TJ coexists with AJ
and desmosome-like junctions at the BTB, which collec-
tively lies adjacent to the basement membrane (a modified
form of ECM, for a review, see [12]), closest to the
interstitium. Thus, toxicants (e.g., cadmium) diffuses from
the microvessels will have immediate access to the E-
cadherin in the AJ (which is the cellular target of cadmium)
at the BTB because there is no TJ-barrier that seals off
cadmium. This, in turn, disrupts AJ, inducing germ cell loss
from the epithelium as manifested by germ cell sloughing in
many of these animal models using environmental toxicants.
It is of interest to note that recent studies have begun to shed
light on the physiological significance of such coexisting TJ
and AJ at the BTB in relation to spermatogenesis. For
instance, it is well understood that spermatogenesis is
associated with extensive restructuring of Sertoli–Sertoli
and Sertoli–germ cell interface because of the constant
reshaping of germ cell shapes as a result of differentiation
and germ cell movement from the basal to the adluminal
compartment. If such AJ restructuring leads to TJ-barrier
disruption as it is the case in other epithelia [193,195,197],
the BTB integrity cannot be maintained, and haploid germ
cell antigens cannot be sequestered from the host immune
system; and such a disruption, even transiently, of the
immunological barrier is detrimental to spermatogenesis.
Thus, the fact that the BTB is constituted by co-existing AJ
and TJ is to ensure such transient disruption of TJ during AJ
restructuring in the seminiferous epithelium does not occur.
Recent studies have shown that a signal that induces AJ
disruption [e.g., via treatment of rats with Adjudin to induce
extensive AJ restructuring that leads to germ cell loss from
the epithelium, or a decline in endogenous intratesticular T
level using androgen/estradiol transdermal implants] can
lead to a surge in the production of both AJ (e.g., cadherins,
catenins) and TJ (e.g., occludin, ZO-1) proteins [30,35,68]
(Fig. 2). The increased TJ proteins are being used to
reinforce the TJ-barrier integrity at the BTB at the time of
extensive AJ restructuring. While the levels of AJ proteins
are also induced, germ cells can still be dissociated from
Sertoli cells because the AJ-integral membrane protein-AJ
adaptor (e.g., the N-cadherin-b-catenin protein complex)
association is found to be weakened via an increase in
tyrosine phosphorylation of b-catenin [30,35,68]. These
findings are significant because it depicts the presence of a
novel mechanism utilized by the testis to ensure TJ-barrier
integrity while permitting AJ restructuring within a
microenvironment such as the seminiferous epithelium.
Fig. 2 is a schematic drawing that illustrates this novel
mechanism of increasing AJ and TJ proteins, which is likely
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regulated by cytokines [e.g., TGF-b3, TNF-a released from
either Sertoli or germ cells [57,113,123,218]] via the ERK
signaling pathway that maintains the BTB integrity while
permitting AJ restructuring, facilitating germ cell movement
across the seminiferous epithelium. However, this same
mechanism that is physiologically necessary to facilitate
germ cell movement while maintaining BTB integrity
during spermatogenesis also makes the BTB extremely
vulnerable to environmental toxicants because of the
unusual exposure of AJ structural proteins (e.g., E-cadherin)
to the toxicants (e.g., cadmium).
6. Conclusion and future perspectives
In all animal species, cell migration and junction
remodeling are naturally occurring processes. For instance,
there are three types of signals that control different aspects
of Drosophila border cell migration: a global steroid-
hormone signal to determine the timing, a highly localized
cytokine signal to induce migration, and a growth factor to
guide cells to their destination (for a review, see [219]). In
the testis, FSH released from the pituitary and testosterone
from Leydig cells may serve as the global regulatory factors.
Cytokines that function as either paracrines or autocrines
can in turn regulate localized signaling and processes.
Several theories of germ cell movement during spermato-
genesis have been proposed, and recently, we have put forth
a junction restructuring theory in which cytokines, protease/
protease inhibitors, cytoskeleton regulators and junctional
complex proteins are all coordinated to facilitate germ cell
movement in the epithelium [2]. Stem cell research has also
offered new insights on Sertoli–germ cell interactions and
may facilitate the research regarding the local regulatory
function of cytokines in this event. When rat spermatogonia
are transplanted into recipient mouse testes, the rat stem
cells develop according to their only timing (7 week
instead of 5 week), irrespective to the surrounding mouse
spermatogenesis milieu [220]. It seems that this internal
preprogrammed rhythm autonomously determines the fate
of rat spermatogonia differentiation, and creates a suitable
localized environment through dialogues with mouse Sertoli
cells, probably via cytokines for crosstalk. This intrinsic
preprogrammed timing may be controlled or executed by
homeobox genes. A homeobox gene cluster Rhox (repro-
ductive homeobox on the X chromosome) has recently been
identified in mice [221]. The 12 Rhox genes are expressed
mostly in reproductive organs (placenta, ovary, testis and
epididymis), arranged into three subclusters and manifested
temporal and quantitative colinearity in expression patterns
[221]. In the testis, the majority of Rhox genes are primarily
expressed in Sertoli cells and androgen responsive [221].
During the first wave of spermatogenesis, the timing of Rhox
genes expression corresponds to the specific phases of germ
cell differentiation. Hence these transcription factors may
direct the expression of an array of proteins required for
germ cell development, and may also define the correspond-
ing timing of epithelial cycle and length of spermatogenesis
in rodents [221].
Several approaches can be used in future studies to aid the
understanding of Sertoli–germ cell crosstalk and junction
restructuring. First, development of testis-specific knockout
mice against crucial proteins pertinent to junction restruc-
turing and spermatogenesis to identify the function of these
proteins in the testis. For many cytokines (e.g., TGF-bs),
their deletion can lead to lethality of the null mice. As such,
their roles in spermatogenesis at adulthood cannot be
examined. In the rat, the first wave of spermiation occurs
only by 30–40 days of age. Recently conditional knockout
technique has allowed investigators to elucidate protein
function in a tissue- and time-specific manner in testis using
specific Sertoli cell KOs, such as androgen receptor [222].
The generation of testis-specific KOs (e.g., TGF-b3) will
help define the roles of these cytokines in junction dynamics
at spermatogenesis. Second, germline stem cell transplanta-
tion with traceable markers to follow germ cell differentia-
tion as well as junction remodeling during spermatogenesis
can assist the study of cell–cell interactions pertinent to
germ cell movement. For instance, when spermatogonia are
transplanted into the recipient testis, they can migrate to the
basal niche and initiate spermatogenesis in the prepro-
grammed cycle independent of the host environment. This
migration must traverse the BTB, differing from gonocyte
migration in the tubule when BTB has not yet formed. Third,
using microarray technique to identify the expression
profiles of various cytokines, proteases and protease
inhibitors, junctional proteins, adaptors and transcription
factors in staged tubules and in testes obtained from selected
in vivo models. This approach can also pinpoint the leading
and supporting biological factors pertinent to spermatogen-
esis. It is hopeful that using these approaches, a better
understanding of spermatogenesis can emerge, which should
be helpful for various applications such as treating male
infertility or for contraception.
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